Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$104,378,005
+$39,247,252 QoQ
Shares Held
87,023
+22.9% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#378
of 4,604 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bridgewater Associates, LP holds $365,428,487 across 9 Drug Manufacturers - General names. LLY ranks #2 (28.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
669,135 | $169,940,215 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
87,023 | $104,378,005 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
290,881 | $36,749,905 | |
| 4 | GSK |
GSK plc
|
504,171 | $26,428,643 | |
| 5 | SNY |
Sanofi
|
206,873 | $8,825,202 | |
| 6 | AMGN |
Amgen Inc
|
21,869 | $7,919,202 | |
| 7 | PFE |
Pfizer Inc
|
180,092 | $4,336,615 | |
| 8 | MRK |
Merck & Co., Inc.
|
30,254 | $3,887,639 |
All Filings in LLY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $104,378,005 | 87,023 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $65,130,753 | 70,812 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $78,765,453 | 73,292 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,966,483 | 10,441 | Shares | Sole | 2025-11-13 | |
| 2025-03-31 | $2,267,948 | 2,746 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $65,122,832 | 84,356 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $64,913,709 | 73,271 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $86,678,365 | 95,737 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $218,129,092 | 280,386 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $185,127,231 | 317,586 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $33,284,334 | 61,967 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $53,409,787 | 113,885 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $89,037,129 | 259,266 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $84,413,189 | 230,738 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $93,400,617 | 288,853 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $66,410,409 | 204,825 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $70,832,474 | 247,346 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $34,007,930 | 123,119 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $10,716,561 | 46,382 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,982,668 | 26,066 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $3,990,974 | 28,770 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||